Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 12,394
- Price
- $16.33
- Value
- $202,437
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•72 filings
AVTX
Avalo Therapeutics, Inc.
Net sales of $1.9M over the last 3 months
3 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$1,931,486
0 buyers · 3 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$8,501,948
6 distinct insiders
Highlighted alerts
3
40 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get AVTX insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
AVTX overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
43
Voluntary view
P/S trades after deterministic checks
66
Administrative noise
Stored, never alerted
77
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- A
- Shares
- 1,109
- Price
- $12.29
- Footnotes
- 2
The options were granted on September 30, 2026, and are 100% vested. The options were issued to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Plan in lieu of Board fees.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 10,185
- Price
- $17.62
- Value
- $179,457
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 679
- Price
- $20.00
- Value
- $13,580
Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 31,031
- Price
- $20.05
- Value
- $622,324
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 1,000
- Price
- $20.00
- Value
- $20,000
Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 3,749
- Price
- $19.94
- Value
- $74,762
Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 37,945
- Price
- $19.85
- Value
- $753,333
Riley Jennifer
Chief Strategy Officer
SaleAlert
- Shares
- 2,655
- Price
- $19.59
- Value
- $52,012
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 679
- Price
- $20.00
- Value
- $13,580
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 1,000
- Price
- $20.00
- Value
- $20,000
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 4,654
- Price
- $20.00
- Value
- $93,080
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 1,450
- Price
- $18.00
- Value
- $26,100
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 679
- Price
- $16.00
- Value
- $10,864
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 3,000
- Price
- $18.76
- Value
- $56,280
Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 18,606
- Price
- $24.12
- Value
- $448,818
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 10,058
- Price
- $22.88
- Value
- $230,127
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 19,015
- Price
- $22.41
- Value
- $426,050
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 44,944
- Price
- $21.20
- Value
- $952,669
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 5,000
- Price
- $19.65
- Value
- $98,251
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 27,538
- Price
- $18.03
- Value
- $496,406
Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 8,900
- Price
- $22.57
- Value
- $200,913
Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 9,219
- Price
- $21.37
- Value
- $197,008
Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 2,700
- Price
- $20.76
- Value
- $56,052
Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 12,347
- Price
- $19.28
- Value
- $238,093
Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 13,834
- Price
- $18.55
- Value
- $256,655
Chan Mitchell
Director
Sale 10b5-1
- Shares
- 3,167
- Price
- $22.88
- Value
- $72,461
VARKI PAUL
Chief Legal Officer
Sale 10b5-1
- Shares
- 400
- Price
- $23.71
- Value
- $9,484
VARKI PAUL
Chief Legal Officer
Sale 10b5-1
- Shares
- 9,253
- Price
- $22.70
- Value
- $210,029
VARKI PAUL
Chief Legal Officer
Sale 10b5-1
- Shares
- 22,839
- Price
- $21.22
- Value
- $484,541
VARKI PAUL
Chief Legal Officer
Sale 10b5-1
- Shares
- 5,196
- Price
- $19.78
- Value
- $102,783
VARKI PAUL
Chief Legal Officer
Sale 10b5-1
- Shares
- 37,375
- Price
- $18.91
- Value
- $706,836
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 1,679
- Price
- $16.00
- Value
- $26,864
Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 8,457
- Price
- $13.23
- Value
- $111,853
Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 8,458
- Price
- $13.09
- Value
- $110,736
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 3,970
- Price
- $18.01
- Value
- $71,508
Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 1,780
- Price
- $17.57
- Value
- $31,270
Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 6,200
- Price
- $17.02
- Value
- $105,553
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 679
- Price
- $16.00
- Value
- $10,864
Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 7,479
- Price
- $16.83
- Value
- $125,841
Sullivan Christopher Ryan
Chief Financial Officer
Sale 10b5-1
- Shares
- 500
- Price
- $15.86
- Value
- $7,929
Doyle Mittie
Chief Medical Officer
Sale 10b5-1
- Shares
- 25,492
- Price
- $16.15
- Value
- $411,607
Goldman Jonathan
Director
SaleAlert
- Shares
- 8,200
- Price
- $14.35
- Value
- $117,649
Goldman Jonathan
Director
SaleAlert
- Shares
- 3,167
- Price
- $14.30
- Value
- $45,288
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 12,394 | $16.33 | $202,437 | |
| Sep 10, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 10,185 | $17.62 | $179,457 | |
| Aug 28, 2026 | Doyle Mittie Chief Medical Officer | Sale | 679 | $20.00 | $13,580 | |
| Aug 18, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 31,031 | $20.05 | $622,324 | |
| Aug 17, 2026 | Doyle Mittie Chief Medical Officer | Sale | 1,000 | $20.00 | $20,000 | |
| Aug 17, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 3,749 | $19.94 | $74,762 | |
| Aug 17, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 37,945 | $19.85 | $753,333 | |
| Aug 11, 2026 | Riley Jennifer Chief Strategy Officer | Sale | 2,655 | $19.59 | $52,012 | |
| Aug 10, 2026 | Doyle Mittie Chief Medical Officer | Sale | 679 | $20.00 | $13,580 | |
| Jul 27, 2026 | Doyle Mittie Chief Medical Officer | Sale | 1,000 | $20.00 | $20,000 | |
| Jun 30, 2026 | Doyle Mittie Chief Medical Officer | Sale | 4,654 | $20.00 | $93,080 | |
| Jun 23, 2026 | Doyle Mittie Chief Medical Officer | Sale | 1,450 | $18.00 | $26,100 | |
| May 28, 2026 | Doyle Mittie Chief Medical Officer | Sale | 679 | $16.00 | $10,864 | |
| May 15, 2026 | Doyle Mittie Chief Medical Officer | Sale | 3,000 | $18.76 | $56,280 | |
| May 07, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 18,606 | $24.12 | $448,818 | |
| May 06, 2026 | Doyle Mittie Chief Medical Officer | Sale | 10,058 | $22.88 | $230,127 | |
| May 06, 2026 | Doyle Mittie Chief Medical Officer | Sale | 19,015 | $22.41 | $426,050 | |
| May 06, 2026 | Doyle Mittie Chief Medical Officer | Sale | 44,944 | $21.20 | $952,669 | |
| May 06, 2026 | Doyle Mittie Chief Medical Officer | Sale | 5,000 | $19.65 | $98,251 | |
| May 06, 2026 | Doyle Mittie Chief Medical Officer | Sale | 27,538 | $18.03 | $496,406 | |
| May 06, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 8,900 | $22.57 | $200,913 | |
| May 06, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 9,219 | $21.37 | $197,008 | |
| May 06, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 2,700 | $20.76 | $56,052 | |
| May 06, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 12,347 | $19.28 | $238,093 | |
| May 06, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 13,834 | $18.55 | $256,655 | |
| May 06, 2026 | Chan Mitchell Director | Sale | 3,167 | $22.88 | $72,461 | |
| May 06, 2026 | VARKI PAUL Chief Legal Officer | Sale | 400 | $23.71 | $9,484 | |
| May 06, 2026 | VARKI PAUL Chief Legal Officer | Sale | 9,253 | $22.70 | $210,029 | |
| May 06, 2026 | VARKI PAUL Chief Legal Officer | Sale | 22,839 | $21.22 | $484,541 | |
| May 06, 2026 | VARKI PAUL Chief Legal Officer | Sale | 5,196 | $19.78 | $102,783 | |
| May 06, 2026 | VARKI PAUL Chief Legal Officer | Sale | 37,375 | $18.91 | $706,836 | |
| May 05, 2026 | Doyle Mittie Chief Medical Officer | Sale | 1,679 | $16.00 | $26,864 | |
| Apr 30, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 8,457 | $13.23 | $111,853 | |
| Apr 29, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 8,458 | $13.09 | $110,736 | |
| Apr 06, 2026 | Doyle Mittie Chief Medical Officer | Sale | 3,970 | $18.01 | $71,508 | |
| Apr 02, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 1,780 | $17.57 | $31,270 | |
| Apr 02, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 6,200 | $17.02 | $105,553 | |
| Apr 01, 2026 | Doyle Mittie Chief Medical Officer | Sale | 679 | $16.00 | $10,864 | |
| Apr 01, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 7,479 | $16.83 | $125,841 | |
| Apr 01, 2026 | Sullivan Christopher Ryan Chief Financial Officer | Sale | 500 | $15.86 | $7,929 | |
| Mar 16, 2026 | Doyle Mittie Chief Medical Officer | Sale | 25,492 | $16.15 | $411,607 | |
| Nov 14, 2025 | Goldman Jonathan Director | Sale | 8,200 | $14.35 | $117,649 | |
| Nov 14, 2025 | Goldman Jonathan Director | Sale | 3,167 | $14.30 | $45,288 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.